CareFusion to Distribute Breas Medical's Vivo Ventilators in US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 1:28PM CST
CareFusion Corp (CFN) recently announced the signing of an exclusive distribution agreement with Breas Medical for the latter's Vivo line of ventilation equipment.
BDX: 143.71 (+0.72), ABAX: 60.93 (+0.65), CFN: 59.81 (+0.01), VASC: 26.44 (+0.79)
Vascular Solutions ups earnings 20% in Q4
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:18AM CST
VASC: 26.44 (+0.79)
Vascular Solutions' (VASC) CEO Howard Root on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 03, 9:33PM CST
VASC: 26.44 (+0.79)
VASCULAR SOLUTIONS
at Investor's Business Daily - Tue Feb 03, 5:35PM CST
VASCULAR SOLUTIONS (VASC), a medical device maker, reported Q4 EPS up 5% to 23 and revenue up 15% to $33.59 mil, both topping. It guided '15 EPS in line and sales above views.
VASC: 26.44 (+0.79)
Vascular Solutions posts 4Q profit
Automated Insights - Tue Feb 03, 5:10PM CST
MINNEAPOLIS (AP) _ Vascular Solutions Inc. (VASC) on Tuesday reported fourth-quarter net income of $4.2 million.
VASC: 26.44 (+0.79)
Vascular Solutions (VASC) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 03, 3:25PM CST
VASC: 26.44 (+0.79)
Vascular Solutions Reports Fourth Quarter Results
GlobeNewswire - Tue Feb 03, 3:18PM CST
- Q4 net revenue increased 15.5% to a record quarterly level of $33.6 million, exceeding the top end of guidance
VASC: 26.44 (+0.79)
Vascular Solutions beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 03, 3:09PM CST
VASC: 26.44 (+0.79)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 4:35PM CST
CALX: 8.65 (-0.03), CHRW: 72.58 (+0.75), WYNN: 159.34 (+4.62), SPA: 22.31 (-0.02), MANH: 51.61 (+0.89), OCLR: 1.55 (+0.09), RSYS: 2.15 (+0.05), NSR: 24.61 (+0.10), CENT: 9.00 (-0.08), CMG: 674.89 (+4.60), AJG: 47.50 (+0.27), IACI: 64.60 (+0.96), VASC: 26.44 (+0.79), SLGN: 56.85 (-0.08), UNM: 34.76 (+0.51), ATW: 33.75 (+0.63), ENTR: 2.92 (unch), AEC: 23.85 (-0.32), AXS: 51.86 (+0.02), MYGN: 34.03 (+0.40), LSCC: 6.10 (+0.02), RNR: 103.80 (-0.64), CBL: 20.52 (-0.14), ATO: 52.52 (-0.65), EW: 134.23 (+1.89), EXP: 81.57 (+2.41), DIS: 104.17 (+0.59), MWA: 9.19 (+0.09), QNST: 6.15 (+0.07), TTWO: 28.40 (+0.96), ULTI: 163.76 (+1.60), PACB: 6.96 (-0.06), FISV: 78.70 (+0.25), GILD: 101.90 (+1.10), JKHY: 65.78 (+0.52), RNG: 16.04 (unch), WNC: 14.01 (+0.38), OMCL: 35.29 (+0.03), AFL: 62.13 (+0.33), HCSG: 33.23 (-0.13), WRB: 50.27 (+0.08), PLNR: 6.63 (-0.07), EQR: 78.75 (-1.11)
Vascular Solutions to Purchase Additional Manufacturing Facility
GlobeNewswire - Wed Jan 28, 7:09AM CST
- Signs agreement to acquire 26,000-square-foot building adjacent to existing manufacturing facility for $2.7 million
VASC: 26.44 (+0.79)
Abaxis' (ABAX) VetScan Feline Test Wins USDA Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 12:50PM CST
Abaxis' novel test kit is used to identify the presence of FeLV antigen and FIV antibodies in blood samples of cats.
ICUI: 88.98 (+0.42), ABAX: 60.93 (+0.65), CNAT: 5.92 (+0.10), VASC: 26.44 (+0.79)
IRadimed (IRMD) Now a Strong Buy on Positive 2015 Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 12:00PM CST
On Jan 21, 2015, Zacks Investment Research raised MRI compatible IV infusion pump systems provider IRadimed Corp (IRMD) to a Zacks Rank #1 (Strong Buy).
IRMD: 14.61 (-0.35), INGN: 33.53 (+2.32), VASC: 26.44 (+0.79), SURG: 4.44 (-0.02)
Baxter's (BAX) PHOXILLUM Solutions Get FDA Nod for CRRT - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 21, 11:20AM CST
Baxter International Inc. (BAX) expects the PHOXILLUM phosphate-containing solutions to be available in the U.S. from the second quarter of 2015.
ICUI: 88.98 (+0.42), ZLTQ: 34.48 (+0.28), BAX: 70.39 (+0.31), VASC: 26.44 (+0.79)
Vascular Solutions, Inc. to Webcast Fourth Quarter Conference Call
GlobeNewswire - Tue Jan 13, 3:05PM CST
Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it will host a live webcast of its fourth quarter conference call on Tuesday, February 3 at 3:30pm CST. Vascular Solutions' Chief Executive Officer, Howard Root, Chief Financial Officer, James Hennen and VP of Corporate Development, Phil Nalbone, will discuss the company's fourth quarter results. The company will issue an earnings news release after market close on Tuesday, February 3.
VASC: 26.44 (+0.79)
Vascular Solutions announces preliminary results
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 9:01AM CST
VASC: 26.44 (+0.79)
Vascular Solutions Surpasses 75,000 Successfully Reprocessed ClosureFAST(R) Catheters
GlobeNewswire - Tue Jan 06, 7:07AM CST
-- After nearly three years on the market, reprocessing service for popular vein ablation catheter continues to gain customers and demonstrate reliable outcomes
VASC: 26.44 (+0.79)
Vascular Solutions Announces FDA 510(k) Clearance of Zigiwire(TM) Access Guidewire System
GlobeNewswire - Fri Dec 19, 7:00AM CST
-- Vascular Solutions will distribute two models of the ZigiWire guidewire system, a novel support wire system designed for gaining vascular access in both simple and challenging peripheral intervention
VASC: 26.44 (+0.79)
Global Markets For Vascular Closure Devices 2014
M2 - Wed Dec 17, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/2kgnwz/global_markets) has announced the addition of the "Global Markets For Vascular Closure Devices" report to their offering. This 2014 report provides a detailed assessment of the current and forecast market. The study also provides a detailed assessment of the competitive landscape including established companies and disruptive emerging companies. The analysis quantifies current and forecast patient populations, procedure volumes, and market size. Competitor sales, unit volumes, ASPs, and market shares are provided for each segment. Key Topics Covered: 1. Executive Summary 2. Overview 3. Vascular Closure Methods And Devices 4. Procedure Forecasts And Market Analysis 5. Company Profiles - Abbott Vascular - AccessClosure (Cardinal Health) - Advanced Vascular Dynamics - Benrikal Services - Cardiva Medical - Cordis Corporation (Johnson & Johnson) - Marine Polymer Technologies - Morris Innovative - Scion BioMedical - St. Jude Medical - TZ Medical - Terumo - Vascular Solutions For more information visit http://www.researchandmarkets.com/research/2k...al_markets
JNJ: 99.62 (+1.18), STJ: 67.48 (+0.65), VASC: 26.44 (+0.79)
AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:50PM CST
AngioDynamics Inc. (ANGO) has entered into a strategic partnership with HealthTrust, covering AngioDynamics' PICC (peripherally inserted central catheter) products.
BCR: 175.38 (+0.50), VASC: 26.44 (+0.79), ANGO: 18.78 (+0.18), MMSI: 17.27 (-0.16)
Vascular Solutions Announces FDA 510(k) Clearance of VSI Radial Introducer Sheath
GlobeNewswire - Mon Dec 08, 7:00AM CST
- Line of 17 models of the VSI Radial(TM) introducer sheath targets vascular access needs in the rapidly-growing radial artery catheterization market
VASC: 26.44 (+0.79)